Table 3.
Prediction of attention and executive factor by the 4 clusters (N = 169)
Cluster | R2 | Adjusted R2 | Std. Error of the Estimate | R2 change | Sig. F change |
---|---|---|---|---|---|
1. Sociodemographic | 0.11 | 0.09 | 0.94 | 11% | <0.01* |
2. Clinical | 0.23 | 0.20 | 0.88 | 13% | <0.01* |
3. Physical | 0.27 | 0.21 | 0.87 | 3% | 0.08 |
4. Mental | 0.29 | 0.23 | 0.87 | 3% | 0.18 |
Unstandardized Coefficients |
Standardized Coefficients |
||||
Variables of final model (4) | B | Std. Error | Beta | Sig. | |
(Constant) | 2.23 | 1.14 | 0.05 | ||
Sex | −0.12 | 0.14 | −0.06 | 0.42 | |
Age | −0.02 | 0.01 | −0.23 | <0.01* | |
Education | 0.45 | 0.14 | 0.23 | <0.01* | |
Hemisphere | 0.38 | 0.15 | 0.19 | 0.01* | |
Antiepileptic drugs | −0.29 | 0.17 | −0.12 | 0.09 | |
Radiotherapy | −0.09 | 0.14 | −0.04 | 0.55 | |
Chemotherapy | −0.51 | 0.26 | −0.15 | 0.05 | |
Disease duration | −0.01 | 0.01 | −0.05 | 0.51 | |
SF-36 physical component summary score | −0.01 | 0.01 | −0.12 | 0.18 | |
QLQ BN-20 visual disorder | −0.01 | 0.05 | −0.01 | 0.91 | |
QLQ BN-20 motor dysfunction | −0.06 | 0.06 | −0.09 | 0.32 | |
SF-36 mental component summary score | 0.01 | 0.01 | 0.07 | 0.45 | |
MFI mental fatigue | −0.01 | 0.02 | −0.04 | 0.62 | |
QLQ BN-20 communication deficit | −0.09 | 0.04 | −0.18 | 0.03* | |
QLQ BN-20 future uncertainty | 0.01 | 0.03 | 0.03 | 0.73 |
Abbreviations: MFI, Multidimensional Fatigue Inventory; QLQ BN-20, Brain cancer specific Quality of Life Questionnaire; SF-36, Medical Outcomes Study Short-Form 36; Std., standard; Sig., significant.